Status:
COMPLETED
COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement
Lead Sponsor:
University of Campinas, Brazil
Collaborating Sponsors:
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Paulínia Municipal Hospital
Conditions:
COVID-19
Therapeutic Vaccine
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To date, there is no vaccine or treatment with proven efficiency against COVID-19, and the transmissibility of the SARS-CoV-2 virus can be inferred by its identification in the oro-nasopharynx. The ba...
Detailed Description
Prospective, randomized, double-blind, multicentre study with international design collaboration with central clinical and mechanistic outcomes with public health implications both epidemiological and...
Eligibility Criteria
Inclusion
- \> 18 years of age;
- laboratory or clinical-epidemiological confirmation of COVID-19 (history of close or home contact with a laboratory-confirmed case who has fever or at least one of the respiratory signs or symptoms, in the last 14 days after contact, and for which it was not possible to carry out the specific laboratory investigation)
Exclusion
- Immunosuppressed patients of any kind;
- Pregnant women;
- More than 14 days from the onset of symptoms;
- Not accept participation or non-signature of the IC;
- Undiagnosed cases, suspected or probable.
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 2 2023
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04369794
Start Date
October 1 2020
End Date
August 2 2023
Last Update
November 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital das Clínicas Unicamp
Campinas, São Paulo, Brazil, 13083-887